Package 0093-0017-01

Brand: moexipril hydrochloride

Generic: moexipril hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0093-0017-01
Digits Only 0093001701
Product NDC 0093-0017
Product ID 0093-0017_2c29e2eb-8956-4fb2-a371-57466c82f348
Description

100 TABLET, FILM COATED in 1 BOTTLE (0093-0017-01)

Marketing

Marketing Status
Marketed Since 2003-05-08
Brand moexipril hydrochloride
Generic moexipril hydrochloride
Sample Package No

Linked Drug Pages (1)

Moexipril Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2c29e2eb-8956-4fb2-a371-57466c82f348", "openfda": {"unii": ["Q1UMG3UH45"], "rxcui": ["1299896", "1299897"], "spl_set_id": ["5d4078f3-b621-475f-a4e6-005de2e62b32"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (0093-0017-01)", "package_ndc": "0093-0017-01", "marketing_start_date": "20030508"}], "brand_name": "Moexipril Hydrochloride", "product_id": "0093-0017_2c29e2eb-8956-4fb2-a371-57466c82f348", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]"], "product_ndc": "0093-0017", "generic_name": "Moexipril Hydrochloride", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Moexipril Hydrochloride", "active_ingredients": [{"name": "MOEXIPRIL HYDROCHLORIDE", "strength": "7.5 mg/1"}], "application_number": "ANDA076204", "marketing_category": "ANDA", "marketing_start_date": "20030508", "listing_expiration_date": "20261231"}